Nomura Securities Raises Price Target on Intel (INTC) to $42

Canaccord Genuity Raises Price Target on Intel (INTC) After Meeting with Management

Canaccord Genuity reiterated a Buy rating on Intel (NASDAQ: INTC), and raised the price target to $44.00 (from $40.00), after meeting with management. meetings were upbeat and focused on the diversification of DCG opportunities and visibility against stronger 2H/16 guidance in DCG. The meetings also covered the KabyLake launch and overall trends toward PC stabilization longer-term, and the recently announced sale of McAfee.

Analyst Matthew Ramsay commented, "After meeting a broad cross-section of Intel management at... More

Brean Capital Raises Price Target as Intel (INTC) Updates Revenue Guidance

Brean Capital reiterated a Buy rating on Intel (NASDAQ: INTC), and raised the price target to $40.00 (from $38.00), as the company increased September quarter revenue expectations. The company now expects revenue to be $15.6B plus or minus $300M versus its previous range of $14.9 billion, plus or minus $500 million.

Analyst Mike Burton... More

UBS Raises Price Target on Intel (INTC) to $43 Ahead of 3Q Report

UBS reiterated a Buy rating on Intel (NASDAQ: INTC), and raised the price target to $43.00 (from $40.00), ahead of the company's 3Q earnings report. UBS believes that the company's stock will continue its positive momentum if Intel executes well in 3Q16 and reports y/y data center sales growth of 15%. Intel's new 3Q16 sales guidance is $15.6B versus its... More

Mizuho Securities Raises Price Target on Intel (INTC) to $42; Reiterates Buy

Mizuho Securities reiterated a Buy rating on Intel (NASDAQ: INTC), and raised the price target to $42.00 (from $38.00), following the company's September quarter preannouncement. INTC raised its midpoint of revenue expectations ~5%, from $14.9B to $15.6B due to PC inventory replenishment and better PC demand.

Analyst Vijay... More

Top 10 News for 9/12 - 9/16: Agrium, Potash Make it Official; Intel Improves Outlook; Wells Fargo Changes Tune, Policies

1. Agrium Inc. (NYSE: AGU) and Potash Corporation of Saskatchewan Inc. (NYSE: POT) announced that they have agreed to combine in a merger of equals. Under the agreement, which the Boards of Directors of both companies unanimously approved, a new parent company will be formed to own both companies. PotashCorp shareholders will receive 0.400 common shares of the new company for each common share of... More

Notable 52-Week Highs and Lows 9/16: (INTC) (AERI) (CRUS) High; (NVAX) (CXRX) (CSIQ) Low

52-Week High:Intel Corporation (Nasdaq: INTC) $38.05. Intel announced that third-quarter revenue is expected to be above the company's previous outlook. The company now expects third-quarter revenue to be $15.6 billion, plus or minus $300 million, as compared to the previous range of $14.9 billion, plus or minus $500 million. The increase in revenue is primarily driven by replenishment of PC supply chain inventory. The company is also seeing some signs of improving PC demand. (The Street was looking for Q3 revenue of $14.9... More

RBC Lifts PT on Intel (INTC) to $38; PCs Supply Chain, Demand Boost Q3 Expectations

RBC Capital boosts its price target on Sector Perform-rated Intel (Nasdaq: INTC) from $36 to $38 following improved Q3 guidance issued earlier Friday.

Analyst Amit Daryanani commented today: INTC updated their Sept-qtr guidance with revenues 5% above prior guidance and an EPS implication 10% above Street estimates. INTC... More

Intel (INTC) Benefiting from Datacenter, Better PC and iPhone, Baird Says; PT to $42

Baird analyst Tristan Gerra reiterated an Outperform rating and boosted estimates and his price target on Intel (NASDAQ: INTC) to $42.00 (from $40.00) after the company raised its Q3 revenue outlook.

The analyst notes the initial iPhone7 teardown shows Intels baseband inside and they... More

Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...)

Today's After-Hours Movers:

Novavax, Inc., (Nasdaq: NVAX) 83% LOWER; announced topline data from two clinical trials of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in older adults. The Resolve trial, a Phase 3 trial of our RSV F Vaccine in 11,856 older adults (60 years of age and older), did not meet the pre-specified primary or the secondary efficacy objectives, and did not demonstrate vaccine efficacy. Consistent with our previous clinical experience, the vaccine was well... More

Intel raises revenue forecast as PC market improves

By Narottam Medhora

(Reuters) - Intel Corp (NASDAQ: INTC) raised its quarterly revenue forecast for the first time in more than two years as suppliers of parts used in personal computers replenish their inventory amid improving PC demand.

Shares of the world's largest chipmaker rose as much as 4.1 percent to a more than 15-year high of $38.05 on Friday.

Intel, which helped found the personal computer industry, has been struggling as tech users shift away from PCs to mobile phones for their computing needs.

Sales in the company's PC business... More

Intel (INTC) September weekly volatility low into raising Q3 revenue expectations

Intel (NASDAQ: INTC) September weekly call option implied volatility is at 19, October is at 26; compared to its 52-week range of 15 to 37 into raising Q3 revenue expectations.

Intel (INTC) Peers Tick Higher on Improved Guidance (MSFT) (AMD)

Advanced Micro Devices (NASDAQ: AMD), HP, Inc. (NYSE: HPQ), and Microsoft (NASDAQ: MSFT) are higher in early trading as Intel (Nasdaq: INTC) raised its Q3 revenue expectations. For more color, click here.

Advanced Micro Devices (AMD) Gains as Intel Raises Outlook

Advanced Micro Devices (NASDAQ: AMD) is up 3% pre-open after Intel (NASDAQ: INTC) raised its revenue outlook.

Wall St. falls; risk of Deutsche Bank fine hits banks

By Noel Randewich

(Reuters) - U.S. stocks fell on Friday as the possibility of a $14 billion fine against Deutsche Bank weighed on big banks and investors wrestled with lingering uncertainty about when the U.S. Federal Reserve will hike interest rates.

The settlement proposal, made during negotiations between the U.S. Department of Justice and Deutsche Bank over claims that the German bank missold mortgage-backed securities, was larger than expected.

Deutsche Bank's U.S.-listed shares (NYSE: DB) slumped 9.35 percent. Dow components Goldman... More

Intel (INTC) Raises Q3 Revenue Outlook

Intel Corporation (Nasdaq: INTC) announced that third-quarter revenue is expected to be above the company's previous outlook. The company now expects third-quarter revenue to be $15.6 billion, plus or minus $300 million, as compared to the previous range of $14.9 billion, plus or minus $500 million. The increase in revenue is primarily driven by replenishment of PC supply chain... More

Teva, Intel to develop wearable technology for Huntington's disease

(Reuters) - Teva Pharmaceutical Industries Ltd (NYSE: TEVA) said on Thursday it was collaborating with Intel Corp (NASDAQ: INTC) to develop a wearable technology platform to track the progression of disease in patients with Huntington's, a fatal degenerative disorder.

The inherited condition causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition and mental stability.

There are no approved drugs to alter the course of Huntington's, although there are medicines that help with symptoms. Patients typically succumb to the... More

Intel (INTC) Declares $0.26 Quarterly Dividend; 2.9% Yield

Intel (NASDAQ: INTC) declared a quarterly dividend of $0.26 per share, or $1.04 annualized.

The dividend will be payable on December 1, 2016, to stockholders of record on November 7, 2016, with an ex-dividend date of November 3, 2016.

The annual yield on the dividend is 2.9 percent.

For a... More